SCHEMBL8959397

SCHEMBL8959397

CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@]13C=C[C@]2(OC(C)=O)[C@@H](OC(C)=O)C3

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.56
CYP3A4 P08684 3/20 0.56
MAPT P10636 3/20 0.56
TP53 P04637 1/20 0.56
ESR1 P03372 4/20 0.49
LMNA P02545 4/20 0.49
ADORA3 P0DMS8 3/20 0.49
ATM Q13315 2/20 0.49
PGR P06401 1/20 0.49
AR P10275 1/20 0.49
CHRM1 P11229 1/20 0.49
TBXA2R P21731 1/20 0.49
ADRA1A P35348 1/20 0.49
OPRM1 P35372 1/20 0.49
SLC6A3 Q01959 1/20 0.49
AKR1C3 P42330 1/20 0.46
KMT2A Q03164 3/20 0.43
RECQL P46063 3/20 0.43
MEN1 O00255 2/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9850289 1.00 SMN1; SMN2 (0.56) SMN1; SMN2CYP3A4MAPTTP53ESR1
SCHEMBL8959390 0.90 CYP3A4 (0.54) SMN1; SMN2CYP3A4MAPTTP53ESR1
SCHEMBL8959356 0.88 SMN1; SMN2 (0.58) SMN1; SMN2CYP3A4MAPTTP53ESR1
SCHEMBL9193105 0.82 CYP3A4 (0.38) SMN1; SMN2CYP3A4MAPTTP53ESR1
SCHEMBL9145265 0.80 SMN1; SMN2 (0.56) SMN1; SMN2CYP3A4MAPTTP53ESR1
SCHEMBL8959363 0.80 SMN1; SMN2 (0.56) SMN1; SMN2CYP3A4MAPTTP53ESR1
SCHEMBL9283651 0.80 ESR1 (0.47) SMN1; SMN2CYP3A4MAPTTP53ESR1
SCHEMBL8959380 0.80 SMN1; SMN2 (0.57) SMN1; SMN2CYP3A4MAPTTP53ESR1
SCHEMBL8959334 0.80 SMN1; SMN2 (0.57) SMN1; SMN2CYP3A4MAPTTP53ESR1
SCHEMBL8959387 0.78 SMN1; SMN2 (0.58) SMN1; SMN2CYP3A4MAPTTP53ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5529993-A UROGENITAL DISORDERS; CONTRACEPTIVES SCHERING AKTIENGESELLSCHAFT (DE) 1996-06-25 US disclosed
EP-0430386-B1 14Alpha, 17alpha bridged 16-hydroxyestratrienes SCHERING AG (DE) 1995-05-03 EP disclosed
EP-0430386-A1 14Alpha, 17alpha bridged 16-hydroxyestratrienes SCHERING AKTIENGESELLSCHAFT (DE) 1991-06-05 EP disclosed